Making flu shots mandatory in 2008 dramatically increased the vaccination rate among St. Louis-based BJC HealthCare’s nearly 26,000 employees to more than 98 percent, according to a report now online in the journal Clinical Infectious Diseases.
The study’s lead author, infectious disease specialist Hilary Babcock, M.D., says the success of the mandatory program demonstrates it is [...]
MISSION STATEMENT
West Coast Ultrasound Institute’s mission is to provide our students with a solid educational foundation in their field of study.
We are dedicated to giving students a well-balanced curriculum, divided between classroom, laboratory and supervised clinical training, taught in a supportive educational environment, by a highly qualified staff of professionals.
It is our responsibility to produce [...]
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK – News), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that MiddleBrook President and CEO John Thievon will be presenting at the Rodman & Renshaw 10th Annual Healthcare Conference at the New York Palace Hotel in New York City on Nov. 11, 2008, at 12:00 [...]
Inverness Medical Innovations, Inc., a leading provider of near-patient diagnostics, monitoring and health management solutions, met yesterday with Ban Ki-moon, the Secretary-General of the United Nations, as part of a group of senior executives of seventeen of the world’s leading research-based and generic pharmaceutical and diagnostic companies. Inverness, together with senior officials from the United [...]
Munir is five years old, and he lives in a ruggedly remote, rural village in Northern Pakistan. For months, he has suffered from an aggressive and worsening skin lesion that, for want of medical care, has gone untreated. But now, his fortunes have changed for the better — as they have for a growing number [...]
Vical Incorporated today is presenting expanded clinical data and new nonclinical data demonstrating that the company’s Vaxfectin® adjuvant may be broadly applicable in DNA- and protein-based infectious disease vaccines and peptide-based cancer vaccines. Alain P. Rolland, Pharm.D., Ph.D., Vical’s Senior Vice President of Product Development, will present the data today, Wednesday, October 8, at the [...]
An early proof-of-concept study presented today shows promising results for imatinib mesylate in the treatment of pulmonary arterial hypertension (PAH), a severe, incurable blood vessel disorder.
Preliminary findings from a 59-patient, multi-center Phase II clinical trial suggest imatinib mesylate provides a treatment benefit, as demonstrated by a significant improvement in pulmonary vascular resistance and a numerical [...]
Bavarian Nordic has now evaluated the mature phase II data from the therapeutic prostate cancer vaccine candidate PROSTVAC(TM) that had been obtained as part of the recently entered partnership with the National Cancer Institute (NCI) in the US.
The results from the Phase II prospective randomized placebo-controlled study of 125 patients with advanced prostate cancer after [...]
Caprion Proteomics Inc. announced today that it has been awarded a $12.9 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the US National Institutes of Health, to carry out Biodefense research in the area of infectious disease biomarkers.
Under the contract to be performed over a five-year period, Caprion [...]
Over 2.5 million nurses are practicing nationwide, according to the Bureau of Labor Statistics (BLS), making nursing the largest workforce within the healthcare industry. There are so many different types and levels of nurses, it can be overwhelming to decide which nursing field to choose.
If compensation and job security are at the top of your [...]